In collaboration with a foundation that breeds service dogs for the visually impaired, researchers at the School of Veterinary Medicine at the University of Pennsylvania and the University of Padova in Padova, Italy, have identified a novel variant associated with progressive retinal atrophy in three Labrador retrievers.
3 min. read
Gustavo D. Aguirre and Leonardo Murgiano of the School of Veterinary Medicine of the University of Pennsylvania.
(Image: John Donges)
In collaboration with a foundation that breeds service dogs for the visually impaired, researchers at the School of Veterinary Medicine at the University of Pennsylvania and the University of Padova in Padova, Italy, have identified a novel variant associated with progressive retinal atrophy in three Labrador retrievers.
In most animals, humans included, vision starts in the retina, where the layers of cells at the back of the eye receive light and convert it into electrical signals that are sent to the brain to create the visual images that are “seen.” Disruption to this process, often the result of inherited retinal diseases (IRDs), can lead to a variety of visual impairments, including blindness, in humans and other mammals such as dogs.
In a recent study published inScientific Reports, researchers at Penn Vet and the University of Padova in Padova, Italy, found a genetic mutation in three Labrador retriever littermates affected by progressive retinal atrophy, the most common classification of IRDs in dogs
These dogs were brought to the attention of Leonardo Murgiano and Gustavo D. Aguirre of Penn Vet and their collaborators by a foundation that breeds service dogs for the visually impaired.
“We have been providing services to guide dog organizations since 1989,” says Aguirre. “When these organizations reach out to us, our aim is to find the mutation and develop a diagnostic test for it so that they can use it to breed dogs without this condition in the future.”
Specifically in this study, the researchers identified a 3-bp deletion in the coding region of GTPBP2, a gene that encodes a G-protein expressed in several tissues—including canine retina. They found that this deletion was linked to the loss of a highly conserved alanine well outside of the GTPase domain of GTPBP2, where the activity of the protein is regulated, toggling it “on” and “off.” Therefore, this finding indicates that loss of this alanine affects a different aspect of the protein, possibly its cellular localization.
Cellular localization of normal (wild-type [WT]) and A536del mutant GTPBP2 proteins. Cells were transfected with WT (a,b) or with A536del mutated GTPBP2 cDNAs (c,d).
(Image: Eylem Emek Akyürek and Roberta Sacchetto; courtesy of Leonardo Murgiano and Gustavo D. Aguirre).
An analysis of 91 non-affected Labrador retrievers from the same kennel and 569 from the general U.S. population identified 16 carriers—all from the original kennel. All other dogs were wild-type—that is, they carried the “normal” version of the gene—highlighting the rarity of this variant.
Mutations in this gene have also been reported in humans; however, these human GTPBP2 genetic variants are associated with Jaberi-Elahi syndrome—human patients typically have neurologic abnormalities such as motor alterations, seizures, and intellectual disabilities as well as general morphologic abnormalities. In contrast, the affected dogs in this study showed no other symptoms other than retinal degeneration/blindness.
“What we report here is a variant that appears to be less severe in our dogs than what is reported in humans, possibly occurring in a different region of the protein—closer to its terminal part,” explains Murgiano. “We have observed this before in genes attributed to syndromes—not all mutations in those genes lead to syndromes. Phenotypes can be flexible, and what we report here is an example of a flexible phenotype. This could have relevance in a general medical genetics landscape.”
Gustavo D. Aguirre is a professor of medical genetics and ophthalmology in the Department of Clinical Sciences & Advanced Medicine and co-director of the Sylvia M. Van Sloun Laboratory for Canine Genomic Analysis at the School of Veterinary Medicine of the University of Pennsylvania.
Leonardo Murgiano is a senior research investigator in the Department of Clinical Sciences & Advanced Medicine and co-director of the Sylvia M. Van Sloun Laboratory for Canine Genomic Analysis Penn Vet.
Other authors are Jessica Niggel of Penn Vet and Eylem Emek Akyürek and Roberta Sacchetto of the University of Padova in Padova, Italy.
This work was supported in part by NEI/NIH RO1-EY006855, The Foundation Fighting Blindness (FFB Large Animal Model Translational and Research Center–Award #RC-CMM-0720-0792-UPA), the Van Sloun Fund for Canine Genetic Research (Sylvia M. Van Sloun Laboratory for Canine Genomic Analysis) and the University of Padova grant from the University of Padova, Italy (DOR-019743 to R.S.).
Nanoparticle blueprints reveal path to smarter medicines
New research involving Penn Engineering shows detailed variation in lipid nanoparticle size, shape, and internal structure, and finds that such factors correlate with how well they deliver therapeutic cargo to a particular destination.
A generous gift from alumni Glenn and Amanda Fuhrman brings the work of internationally acclaimed artist Jaume Plensa to the University of Pennsylvania. The latest addition to the Penn Art Collection expands Philadelphia's public art.
A massive chunk of ice, a new laser, and new information on sea-level rise
For nearly a decade, Leigh Stearns and collaborators aimed a laser scanner system at Greenland’s Helheim Glacier. Their long-running survey reveals that Helheim’s massive calving events don’t behave the way scientists once thought, reframing how ice loss contributes to sea-level rise.
![Cellular localization of normal (wild-type [WT]) and A536del mutant GTPBP2 proteins.](/sites/default/files/styles/900px_wide_with_focal_crop/public/2025-03/MURG_FIGURE%20higher%20res.png?h=84be0ba1&itok=nkiK3gCo)
